BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 33012377)

  • 21. Explosion in mortality in the Amazonian epicenter of the COVID-19 epidemic 19.
    Orellana JDY; Cunha GMD; Marrero L; Horta BL; Leite IDC
    Cad Saude Publica; 2020; 36(7):e00120020. PubMed ID: 32638881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excess all-cause mortality during the COVID-19 pandemic in Europe - preliminary pooled estimates from the EuroMOMO network, March to April 2020.
    Vestergaard LS; Nielsen J; Richter L; Schmid D; Bustos N; Braeye T; Denissov G; Veideman T; Luomala O; Möttönen T; Fouillet A; Caserio-Schönemann C; An der Heiden M; Uphoff H; Lytras T; Gkolfinopoulou K; Paldy A; Domegan L; O'Donnell J; De' Donato F; Noccioli F; Hoffmann P; Velez T; England K; van Asten L; White RA; Tønnessen R; da Silva SP; Rodrigues AP; Larrauri A; Delgado-Sanz C; Farah A; Galanis I; Junker C; Perisa D; Sinnathamby M; Andrews N; O'Doherty M; Marquess DF; Kennedy S; Olsen SJ; Pebody R; ; Krause TG; Mølbak K
    Euro Surveill; 2020 Jul; 25(26):. PubMed ID: 32643601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Collateral damage: Hidden impact of the COVID-19 pandemic on the out-of-hospital cardiac arrest system-of-care.
    Ball J; Nehme Z; Bernard S; Stub D; Stephenson M; Smith K
    Resuscitation; 2020 Nov; 156():157-163. PubMed ID: 32961304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters.
    Ioannidis JPA; Axfors C; Contopoulos-Ioannidis DG
    Environ Res; 2020 Sep; 188():109890. PubMed ID: 32846654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19, Australia: Epidemiology Report 17 (Fortnightly reporting period ending 24 May 2020).
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2020 Jun; 44():. PubMed ID: 32517645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.
    Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF
    J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence-based crisis standards of care for out-of-hospital cardiac arrests in a pandemic.
    Natalzia P; Murk W; Thompson JJ; Dorsett M; Cushman JT; Reed P; Clemency BM;
    Resuscitation; 2020 Nov; 156():149-156. PubMed ID: 32758516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tracking excess deaths associated with the COVID-19 epidemic as an epidemiological surveillance strategy-preliminary results of the evaluation of six Brazilian capitals.
    Freitas ARR; Medeiros NM; Frutuoso LCV; Beckedorff OA; Martin LMA; Coelho MMM; Freitas GGS; Lemos DRQ; Cavalcanti LPG
    Rev Soc Bras Med Trop; 2020; 53():e20200558. PubMed ID: 33174964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with increased all-cause mortality during the COVID-19 pandemic in Italy.
    Mannucci E; Nreu B; Monami M
    Int J Infect Dis; 2020 Sep; 98():121-124. PubMed ID: 32599284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temporal dynamics in total excess mortality and COVID-19 deaths in Italian cities.
    Michelozzi P; de'Donato F; Scortichini M; Pezzotti P; Stafoggia M; De Sario M; Costa G; Noccioli F; Riccardo F; Bella A; Demaria M; Rossi P; Brusaferro S; Rezza G; Davoli M
    BMC Public Health; 2020 Aug; 20(1):1238. PubMed ID: 32795276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High mortality among hospital-acquired COVID-19 infection in patients with cancer: A multicentre observational cohort study.
    Elkrief A; Desilets A; Papneja N; Cvetkovic L; Groleau C; Lakehal YA; Shbat L; Richard C; Malo J; Belkaid W; Cook E; Doucet S; Tran TH; Jao K; Daaboul N; Bhang E; Loree JM; Miller WH; Vinh DC; Bouganim N; Batist G; Letendre C; Routy B
    Eur J Cancer; 2020 Nov; 139():181-187. PubMed ID: 33035991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spatial modeling, risk mapping, change detection, and outbreak trend analysis of coronavirus (COVID-19) in Iran (days between February 19 and June 14, 2020).
    Pourghasemi HR; Pouyan S; Heidari B; Farajzadeh Z; Fallah Shamsi SR; Babaei S; Khosravi R; Etemadi M; Ghanbarian G; Farhadi A; Safaeian R; Heidari Z; Tarazkar MH; Tiefenbacher JP; Azmi A; Sadeghian F
    Int J Infect Dis; 2020 Sep; 98():90-108. PubMed ID: 32574693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.
    COVID-19 Excess Mortality Collaborators
    Lancet; 2022 Apr; 399(10334):1513-1536. PubMed ID: 35279232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurological complications in a predominantly African American sample of COVID-19 predict worse outcomes during hospitalization.
    Chachkhiani D; Soliman MY; Barua D; Isakadze M; Villemarette-Pittman NR; Devier DJ; Lovera JF
    Clin Neurol Neurosurg; 2020 Oct; 197():106173. PubMed ID: 32877769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute Kidney Injury in COVID-19 Patients: An Inner City Hospital Experience and Policy Implications.
    Zahid U; Ramachandran P; Spitalewitz S; Alasadi L; Chakraborti A; Azhar M; Mikhalina G; Sherazi A; Narh JT; Khattar P; Bedi P
    Am J Nephrol; 2020; 51(10):786-796. PubMed ID: 33011717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
    Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
    Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mortality impacts of the coronavirus disease (COVID-19) outbreak by sex and age: rapid mortality surveillance system, Italy, 1 February to 18 April 2020.
    Michelozzi P; de'Donato F; Scortichini M; De Sario M; Noccioli F; Rossi P; Davoli M
    Euro Surveill; 2020 May; 25(19):. PubMed ID: 32431289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signal of increased opioid overdose during COVID-19 from emergency medical services data.
    Slavova S; Rock P; Bush HM; Quesinberry D; Walsh SL
    Drug Alcohol Depend; 2020 Sep; 214():108176. PubMed ID: 32717504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How Large Was the Mortality Increase Directly and Indirectly Caused by the COVID-19 Epidemic? An Analysis on All-Causes Mortality Data in Italy.
    Magnani C; Azzolina D; Gallo E; Ferrante D; Gregori D
    Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32429172
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.